These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8058056)

  • 21. Fetal ventral mesencephalic grafts functionally reduce the dopamine D2 receptor supersensitivity in partially dopamine reinnervated host striatum.
    Strömberg I; Kehr J; Andbjer B; Fuxe K
    Exp Neurol; 2000 Jul; 164(1):154-65. PubMed ID: 10877926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine D2, receptor-mediated modulation of the GABAergic inhibition of substantia nigra pars reticulata neurons.
    Martin LP; Waszczak BL
    Brain Res; 1996 Aug; 729(2):156-69. PubMed ID: 8876984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infusions of tyrosine hydroxylase antisense oligodeoxynucleotide into substantia nigra of the rat: effects on tyrosine hydroxylase mRNA and protein content, striatal dopamine release and behaviour.
    Skutella T; Schwarting RK; Huston JP; Sillaber I; Probst JC; Holsboer F; Spanagel R
    Eur J Neurosci; 1997 Feb; 9(2):210-20. PubMed ID: 9058042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host.
    Bentlage C; Nikkhah G; Cunningham MG; Björklund A
    Exp Neurol; 1999 Sep; 159(1):177-90. PubMed ID: 10486186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strain differences in the effects of adrenalectomy on the midbrain dopamine system: implication for behavioral sensitization to cocaine.
    de Jong IE; Steenbergen PJ; de Kloet ER
    Neuroscience; 2008 May; 153(3):594-604. PubMed ID: 18420350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrastriatal administration of an oligodeoxynucleotide antisense to the D2 dopamine receptor mRNA inhibits D2 dopamine receptor-mediated behavior and D2 dopamine receptors in normal mice and in mice lesioned with 6-hydroxydopamine.
    Zhou LW; Zhang SP; Weiss B
    Neurochem Int; 1996 Dec; 29(6):583-95. PubMed ID: 9113126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine D1 or D2 receptor antagonism within the basolateral amygdala differentially alters the acquisition of cocaine-cue associations necessary for cue-induced reinstatement of cocaine-seeking.
    Berglind WJ; Case JM; Parker MP; Fuchs RA; See RE
    Neuroscience; 2006; 137(2):699-706. PubMed ID: 16289883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine and serotonin release-regulating autoreceptor sensitivity in A9/A10 cell body and terminal areas after withdrawal of rats from continuous infusion of cocaine.
    Chen NH; Reith ME
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1445-53. PubMed ID: 8263807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Day/night differences in D1 but not D2 DA receptor protection from EEDQ denaturation in rats treated with continuous cocaine.
    Burger LY; Martin-Iverson MT
    Synapse; 1993 Jan; 13(1):20-9. PubMed ID: 8093985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antisense oligonucleotides fail to inhibit the expression of central beta adrenergic receptors.
    Zhang K; O'Donnell JM
    Res Commun Mol Pathol Pharmacol; 1997 Jan; 95(1):21-32. PubMed ID: 9055346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that systemically administered dopamine antagonists activate dopamine neuron firing primarily by blockade of somatodendritic autoreceptors.
    Pucak ML; Grace AA
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1181-92. PubMed ID: 7996424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic activation of the D2 dopamine autoreceptor inhibits synaptogenesis in mesencephalic dopaminergic neurons in vitro.
    Fasano C; Poirier A; DesGroseillers L; Trudeau LE
    Eur J Neurosci; 2008 Oct; 28(8):1480-90. PubMed ID: 18973573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. D
    López-Ramírez G; Sánchez-Zavaleta R; Ávalos-Fuentes A; José Sierra J; Paz-Bermúdez F; Leyva-Gómez G; Segovia Vila J; Cortés H; Florán B
    Synapse; 2020 Mar; 74(3):e22139. PubMed ID: 31610050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons.
    Dragicevic E; Poetschke C; Duda J; Schlaudraff F; Lammel S; Schiemann J; Fauler M; Hetzel A; Watanabe M; Lujan R; Malenka RC; Striessnig J; Liss B
    Brain; 2014 Aug; 137(Pt 8):2287-302. PubMed ID: 24934288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine D3 autoreceptor inhibition enhances cocaine potency at the dopamine transporter.
    McGinnis MM; Siciliano CA; Jones SR
    J Neurochem; 2016 Sep; 138(6):821-9. PubMed ID: 27393374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of oligonucleotide antisense to dopamine D(1A) receptor messenger RNA in a rodent model of levodopa-induced dyskinesia.
    Van Kampen JM; Stoessl AJ
    Neuroscience; 2000; 98(1):61-7. PubMed ID: 10858612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of nigrostriatal dopaminergic transmission by antisense oligodeoxynucleotide against brain-derived neurotrophic factor.
    Lau YS; Hao R; Fung YK; Fu LS; Bishop JF; Pfeiffer RF; Mouradian MM
    Neurochem Res; 1998 Apr; 23(4):525-32. PubMed ID: 9566587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-methyl-D-aspartate-R1 receptor antisense oligodeoxynucleotide modulates pre- and postsynaptic expression of D2 dopamine receptors in the rat.
    Murata M; Suzuki M; Tanaka K; Tajiri K; Emori K; Kurachi M
    Neurosci Lett; 2002 Dec; 335(1):9-12. PubMed ID: 12457730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antisense oligodeoxynucleotides for in vivo targeting of corticotropin-releasing hormone mRNA: comparison of phosphorothioate and 3'-inverted probe performance.
    Skutella T; Stöhr T; Probst JC; Ramalho-Ortigao FJ; Holsboer F; Jirikowski GF
    Horm Metab Res; 1994 Oct; 26(10):460-4. PubMed ID: 7851868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A single (-)-nicotine injection causes change with a time delay in the affinity of striatal D2 receptors for antagonist, but not for agonist, nor in the D2 receptor mRNA levels in the rat substantia nigra.
    Li XM; Zoli M; Finnman UB; Le Novère N; Changeux JP; Fuxe K
    Brain Res; 1995 May; 679(1):157-67. PubMed ID: 7648259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.